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Bone-marrow-derived mesenchymal stromal cells (MSCs) are currently consid-
ered among the best candidates for cell-based therapy in regenerative medicine due 
to their ability to secrete paracrine factors with multiple effects on the injured tis-
sue, including modulation of inflammation and immune reaction, ECM remodeling, 
angiogenesis and protection from apoptosis [1]. Moreover, MSCs have been proved, 
in some tissues, to affect the fate of resident progenitor cells by positively influenc-
ing the endogenous mechanisms of tissue repair/regeneration [2,3]. We have recently 
demonstrated that MSCs are able to produce and secrete sphingosine 1-phosphate 
(S1P), a bioactive lipid exerting a broad range of biological responses in many cell 
types [4]. On these bases, the aim of this study was to evaluate whether S1P could 
exert an autocrine effect on MSCs, influencing expression and release of enzymes 
involved in the ECM remodeling, namely matrix metalloproteinases (MMPs), such 
as MMP2 and its activator MT1-MMP/MMP14. By multiple approaches (confocal 
immunofluorescence, western blotting, zymography and gelatinase assays) we first 
found that MSCs express and release active MMP2 and MT1-MMP/MMP14. These 
cellular events appear to be mediated by S1P1, a specific G-coupled receptor subtype 
of the bioactive lipid, abundantly expressed in MSCs. In fact, when MSCs were cul-
tured in the presence of a specific S1P1 antagonist (W146) they exhibited a down-reg-
ulation of MMP2 and MT1-MMP/MMP14; of note the addition of a receptor agonist 
(SEW 2871) was not able to up-regulate MMPs thus suggesting that S1P1 signalling 
plays a trophic role in MSCs. In parallel experiments, the expression of MMP2 and 
MT1-MMP/MMP14 was evaluated in MSCs cultured in low oxygen conditions (2%) 
in order to mimic the hypoxic microenvironment occurring in a damaged/regenerat-
ing tissue. These preliminary data contribute to add new insights into the functional 
mechanisms by which MSCs exert beneficial effects on tissue repair/regeneration. 
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